Health

Leaders from Northwell’s Cancer Institute and its Center for Genomic Medicine celebrate the opening of the Molecular Diagnostic Laboratory. From left to right, Joseph Castagnaro, Jeff Boyd, Dwayne Breining, Richard Barakat, Naima Loayza, Anna Razumova, Angelo Carbone, Rita Mercieca and Kathryn Cashin. Photo courtesy of Northwell Health

By Daniel Dunaief

Northwell Health Cancer Institute and its Center for Genomic Medicine opened a Molecular Diagnostics Laboratory, which will reduce the cost of testing and shorten the time to get test results for cancer tests.

At a cost of $3.2 million, the 2,800 square foot facility will use next generation sequencing to provide tumor and patient genomic profiling and to assist in testing for biomarkers and determining the choice of cancer therapy.

The MDL, which is using the space Northwell Health Labs owned, will offer an array of tests in a phased approach. It is starting with a set of single gene tests to inform precision therapies for lung, melanoma, pancreatic, and colorectal cancer, which can be conducted in 24 to 72 hours.

“We like to get cancer therapy started as soon as possible for patients with metastatic disease,” said Jeff Boyd, vice president and chief scientific officer and director of the Northwell Health Cancer Institute’s Center for Genomic Medicine. When Northwell sent out similar tests to for-profit centers, the results, depending on the test, could take weeks.

The MDL is performing these tests on patients with advanced stage disease and/or recurrent diseases, which increases the need to generate results quickly.

“That makes a huge difference for the ordering oncologist and, most especially and importantly to the patient,” said Boyd. “The sooner they can get on precision therapeutics to treat the disease, the better. Outcomes will reflect wait time until you get therapy.”

Northwell treats more New York residents for cancer than any provider in the state, according to the Statewide Planning and Research Cooperative System, inpatient and ambulatory surgery data. 

The center, which is located in Lake Success, started conducting tests several weeks ago.

The lab is using high-end DNA sequencing to extract and define the genomic details of each tumor. Each patient tumor is different, which affects decisions about the best possible treatment.

“When the diagnosis isn’t totally clear to the pathology team, the genetics of the cancer will often inform the diagnosis,” said Boyd. Some patients with the same type of tumor will respond differently to radiation.

The lab is offering four single-gene tests: EGF for non-small cell lung cancer, BRAF for melanoma, KRAS for colorectal, pancreatic and lung cancers, and BRAF/NRAS for melanoma.The MDL plans to offer a 161-gene NGS panel for solid malignancies, a 45-gene NGS panel for hematologic malignancies, and MSI-H, a genetic test that reveals whether tumors will respond to immunotherapy.

Long road

Northwell recruited Boyd to start a molecular diagnostic lab four years ago. He started working in February of 2020, a month before the pandemic caused local, state, national and worldwide disruption.

While he has other responsibilities, Boyd suggested that his “primary reason” for joining Northwell was to “create and direct a Center for Genomic Medicine.”

Northwell conducted extensive physical renovation of the core lab facility that houses the MDL. Northwell also hired six people for the MDL, which includes a lab director, a lab manager, two certified lab technicians, a director of bioinformatics and an LIMS administrator.

In addition, New York State Department of Health had to certify the tests. Northwell is working through certification for additional tests.

Patients don’t need to go to the Lake Success facility to benefit from the services offered by the lab.The cost to patients for these tests is less than it would be for a for profit lab, Boyd said.

“We are a non profit and all we’re looking for is the sustainability of the lab infrastructure,” he added.

At this point, the lab isn’t conducting any germ line testing to determine if there are genetic predispositions to various cancers.

“That might be one of those tests we role out in the future,” Boyd said.

For Boyd, who earned a PhD in toxicology and biochemistry from North Carolina State University in Raleigh, the work is particularly rewarding.

To see his job “impact care tomorrow” based on a particular genetic alteration, “it doesn’t get much better than that for an individual with my background and profession,” he said.

Gov. Kathy Hochul speaking with Cold Spring Harbor Laboratory CEO Bruce Stillman during a recent visit. Photo courtesy of Darren McGee/ Office of Governor Kathy Hochul

By Daniel Dunaief

The transition from studying pancreatic cancer’s playbook to attempting new moves to wrestle it into submission is getting closer at Cold Spring Harbor Laboratory, thanks to support from New York State.

Recently, Governor Kathy Hochul (D) announced that the Empire State would contribute $15 million to a new Pancreatic Cancer Center at Cold Spring Harbor Laboratory as a part of the lab’s Foundations for the Future Expansion.

The funds will support the construction of a new center that will continue to try to defeat this insidious type of cancer as CSHL aims to develop new treatments.

“Patients should not feel there’s no chance and no hope” after a pancreatic cancer diagnosis, said David Tuveson, Director of the CSHL Cancer Center and a researcher whose lab has taken innovative approaches to pancreatic cancer. “They are watching the evolution of an area in a disease that previously has been challenging to treat. Through fundamental research, we are coming up with new approaches.”

As CSHL works with human organoids, which are tissues grown from a patient’s own cancer cells that can be used to test the effectiveness of various treatments and any resistance from cancer, animal models, and other techniques, they have moved closer to finding targets that could lead to new therapies.

Any novel treatment would likely involve creating new companies, likely on Long Island, that could develop these treatments, file for patents, and build a commercial presence and infrastructure.

“It’s an investment by the state to accelerate our translational research so we can go from preclinical to clinical,” said Tuveson. “Part of that will be to generate private entities that can focus on turning a lead to first-in-class, first-in-human products. It allows us to build that infrastructure.”

Tuveson has been working on a potential treatment for several years. Other potential treatments are also in the earlier stages of development.

Governor Hochul suggested that the state’s investment fits in the context of an overall goal to boost the local economy with new biotechnology companies.

“New York State is leading on innovative healthcare space, and this funding will advance research to better understand pancreatic cancer – one of the most devastating forms of cancer,” Governor Hochul said in a statement.

Big Picture

The Pancreatic Cancer Center will take a wide range of approaches to this particular type of cancer.

The Center will be, along with Northwell Health, a “pipeline from fundamental discovery science” to clinical trials conducted with hospital partners, explained Bruce Stillman, CEO of Cold Spring Harbor Laboratory.

The center will address early detection as well.

For Tobias Janowitz, Associate Professor and Cancer Center Program Co-Leader at CSHL, the investment means “we can strengthen collaborations between experts in metabolism, immunology, cancer cell biology, and whole body effects of cancer, all of them interconnected and relevant to therapy development in pancreatic cancer.”

Janowitz explained that patients with pancreatic cancer have the highest incidence of cachexia, in which chronic illness causes a reduction in muscle and fat, lowers people’s interest in food and causes extreme and potentially terminal weight loss. Pancreatic cancer patients almost universally experience a loss of appetite and profound weight and muscle loss.

Understanding cachexia in the context of pancreatic cancer will “enable care for patients with other cancers, too,” Janowitz added.

From that perspective, Janowitz hopes the New York State funds could enable discoveries that reach beyond pancreatic cancer.

As an MD/PhD, Janowitz could be involved in the translation of fundamental discoveries into clinical research and, ultimately, clinical care.

Janowitz has a specific interest in optimizing the therapeutic window for patients with pancreatic cancer.

“We are looking for management options that intensify the anti-cancer effect,” while, at the same time, protecting or reconditioning the whole body, Janowitz added.

Janowitz is using special transcriptomics on clinical samples in collaboration with Jon Preall, who leads the genomics core facility.

In a statement, Cold Spring Harbor Laboratory Chair Marilyn Simons described the state funding as a “catalyst to mobilize further private investment in pancreatic cancer research at CSHL.”

Simons added that her father was diagnosed with pancreatic cancer at the age of 75. A doctor offered him an exploratory operation, which enabled him to live another 14 years.

“Few people are so lucky,” Simons added in a statement. “Our wonderful scientists at Cold Spring Harbor are working with Northwell Health and the Feinstein Institutes to help more people get access to the latest biomedical advances.”

Carol Gomes with NYS Sen. Anthony Palumbo at Senate Women of Distinction event in Albany. Photo courtesy Office of Anthony Palumbo

State Sen. Anthony Palumbo (R-New Suffolk) proudly announced Carol Gomes as the 2024 New York State Woman of Distinction for the 1st Senate District at this year’s annual New York State Senate Women of Distinction event at the state capitol.

“Today marks a celebration of extraordinary dedication and leadership in health care,” Palumbo said. “It is my great privilege to honor Carol Gomes as my 2024 New York State Woman of Distinction.”

On Tuesday, May 14, Gomes of Mount Sinai, joined Palumbo and guests at the New York State Senate in Albany for her recognition. As chief executive officer of Stony Brook University Hospital, Gomes has demonstrated an unparalleled commitment to excellence in health care.

“It is an honor and privilege to stand beside the many accomplished women leaders in New York State for this prestigious recognition,” Gomes said.

With over 35 years of experience, Gomes has played a pivotal role in elevating Stony Brook University Hospital to its status as Long Island’s premier academic medical center. Her leadership as CEO and COO has propelled the hospital to new heights of innovation and patient care.

Under Gomes’ guidance, Stony Brook Medicine completed its largest expansion project in 2019, including the opening of the Medical and Research Translation, Stony Brook Children’s and Hospital Pavilion. Her strategic vision and operational excellence have positioned Stony Brook University Hospital as a beacon of cutting-edge health care delivery.

“Carol Gomes’ remarkable achievements and unwavering dedication make her a true inspiration to us all,” Palumbo said. “Her leadership in health care has touched countless lives, and her commitment to excellence sets a standard for others to follow.”

As a recipient of numerous leadership awards, including recognition from the American Society of Clinical Pathology and recipient of the American College of Healthcare Executives Award of Distinction, Gomes’ impact extends far beyond the walls of Stony Brook University Hospital. Her leadership in sustainability efforts and commitment to quality care have earned her the respect and admiration of colleagues and peers alike.

“Her contributions to health care in our community and beyond are immeasurable, and her legacy will continue to inspire future generations,” Palumbo said.

The Suffolk County Water Authority celebrated Drinking Water Week (May 5 to 11) with the opening of a new expansion of its state-of-the-art laboratory. The expansion will support SCWA’s mission of providing its customers with high quality drinking water.

SCWA’s water quality testing laboratory is recognized as one of the top groundwater laboratories in the nation. With the 191,047 tests performed last year producing 1.7 million results, it is at the front line of ensuring that SCWA is delivering high quality water. With a growing number of contaminants that water providers are required to test for, SCWA began an expansion of its laboratory in 2023.

The new area consolidates the collection of samples collected from SCWA’s public supply system around Suffolk County and distributes them throughout the laboratory so testing can occur for pesticides, herbicides, emerging contaminants, bacteria, metals and many other compounds. It also provides ample room within its existing laboratory to prepare for the future testing requirements. It is the laboratory’s largest expansion since it moved to its current location in Hauppauge in 1994.

SCWA Chairman Charlie Lefkowitz cut the ribbon on the new expansion, remarking “We are so proud of our state-of-the-art laboratory and the staff that makes it the finest in the nation. Wherever I go, I always talk about its importance so our customers will know the rigor and attention that goes into making sure their drinking water is of the highest quality. This expansion sets us up for the future and I am thrilled to be here to celebrate it.”

Dr. Allan Zhang

New York Health (NY Health) has announced the addition of Interventional Pain Specialist Dr. Allan Zhang. Dr. Zhang will practice at 5316 Nesconset Hwy, Port Jefferson Station.

“We are excited to welcome Dr. Zhang to NY Health, ” said Dr. Chris Ng, Chief Medical Officer and Executive Director of NY Health. “His training and thoughtful approach reassure patients that they receive the best care to manage their pain and maintain their normal daily routines.”

Dr. Zhang specializes in spine-related diseases and pain, treating patients presenting with radiculopathies and lower back arthritis. Treatment is multimodal, involving physical therapy, cognitive behavior therapy,
medications, and different interventional procedures ranging from epidurals, radiofrequency ablations, peripheral nerve stimulation, and spinal cord stimulators. In addition to spine-related disease, Dr. Zhang also treats patients with degenerative joint disease, knee pain, shoulder pain, chronic regional pain syndrome (CRPS), headaches, abdominal pain, and pelvic pain. Many patients experience pain relief from sympathetic nerve blocks and spinal cord stimulation.

Dr. Zhang believes every patient is unique and must be treated with an individualized plan. Chronic pain patients are complex and require an individualized treatment plan that involves both patient and physician participation, a multimodal approach, and novel innovation.

With a background as a diagnostic radiologist, Dr. Zhang has often seen the reason for the patient’s presenting symptoms based on MRI, CT, or other forms of imaging. He would dictate the report’s findings, and then that would be the end of his patient care experience. With his additional fellowship training in interventional pain management, Dr. Zhang can provide comprehensive and multifaceted pain management care, from when patients first present in the office to their follow-up after interventional treatment.

Dr. Zhang earned his Doctor of Medicine at Lake Erie College of Osteopathic Medicine. He completed an Internal Medicine Internship at Yale-Griffin Hospital, an Anesthesiology Residency and Diagnostic Radiology at the University of Connecticut, where he served as Chief Resident. Dr. Zhang further honed his skills through an ACGME Pain Management Fellowship at the University of Virginia. In 2020, he became board-certified in Diagnostic Radiology.

“I am excited to be part of NY Health to work in an environment where I have access to world-class facilities, exceptional physician colleagues, and the opportunity to help patients,” said Dr. Zhang.

To make an appointment with Dr. Zhang, please call 833-660-7246. For more information, visit nyhealth.com.

About New York Health

New York Health (NYHealth) is the premier center for primary and specialty care services. Our network of outstanding physicians specialize in family medicine, internal medicine, physical therapy, nephrology, rheumatology, surgery, urology, OB/GYN, and interventional spine and pain. At NY Health, we are dedicated to healthcare excellence and provide highly professional, sensitive, and personalized care. For more information, visit nyhealth.com.

Dr. John Fitzgerald

New York Health (NY Health) has announced that board-certified Urologist Dr. John Fitzgerald has joined its Urology team.

Dr. Fitzgerald will practice at:  5316 Nesconset Highway, Port Jefferson Station; 300 Old Country Road, Riverhead; 1061 N. Broadway, 2nd Fl, North Massapequa; and 1055 Stewart Avenue, Bethpage.

“Dr. Fitzgerald joins NY Health, bringing tremendous clinical experience in treating all types of urological malignancies and improving quality of life with minimally invasive treatments in a patient-centric fashion. He is fully supported by our first-in-class oncologists, who are thrilled with this new addition to our physician family,” said Dr. Chris Ng, Chief Medical Officer and Executive Director of NY Health.

Dr. Fitzgerald is an experienced urologic oncologist who specializes in the surgical management of kidney, prostate, and bladder, as well as other genitourinary malignancies, which are treated with any approach. He  also has expertise in the treatment of non-malignant diseases, including BPH and kidney stones.

“I feel that no matter what the issue, a patient should feel better upon leaving a doctor’s office than when walking in,” he said.

Dr. Fitzgerald earned his Doctor of Medicine at University College Dublin in Ireland. He then completed residency training at Brookdale University Hospital in Brooklyn, where he was named Chief Resident. Dr. Fitzgerald completed his Urology Oncology Fellowship at the University of Texas at San Antonio, where he earned his Master of Science in Clinical Investigation (MScI). He is certified by the American Board of Urology and the Society of Urologic Oncology (SUO). He serves as the Chief of Urology and the director of robotics at Northport VAMC, where he spearheads innovative approaches to urologic surgery and ensures the highest standards of care for his patients. Additionally, he has been recognized as a Top Doctor by Castle Connolly and Newsday.

To make an appointment with Dr. Fitzgerald, please call 631-663-4850.

For more information, visit www.nyhealth.com.

More than 200 guests and 40 elder care industry sponsors and exhibitors gathered for the annual Cona Elder Law Caregiver Conference at the Hilton Long Island/Huntington in Melville on May 8 to discuss “The Loneliness Epidemic: Tackling Isolation, Care Needs & Finances In Senior Living,”

This year’s conference focused on social senior living options and explore key differences between assisted living, independent living, continuing care retirement communities, the ALP program and the CDPAP program, allowing different options for family and financial support.

“Loneliness has been declared a public health epidemic by the US Surgeon General because it reportedly leads to an increased risk of heart disease, stroke, and depression,” said Jennifer Cona, Founder and Managing Partner of Cona Elder Law, located in Melville. “The majority of adults aged 65 and older report feeling lonely. For this already vulnerable population, it is critical that we consider alternatives to aging-in-place.”

Topics also included financing senior living, including asset protection planning, Medicaid planning and eligibility, and provide practical tips for determining the best way to finance needed care and services.

Presenting Sponsors Included: Cona Elder Law, Gurwin Healthcare Systems, Amber Court Assisted Living, The Bristal Assisted Living, Encore Luxury Living, Community Care Home Health Services, and Family & Children’s Association. 

Conference Sponsors included: SeniorCare Companions, Inc., Life’s WORC, Long Island Alzheimer’s & Dementia Center, Heritage Harbor Financial Associates, Jerusalem Memorial Chapels, Senior Health Plan Specialists Inc., Handled Real Estate, Centerlight Healthcare, Alzheimer’s Association, and M&T Bank.

Cona Elder Law also presented its annual Caregiver of the Year award at the conference to David Marshall, of Baldwin, a dedicated husband who has helped and supported his wife of 75 years as she lives with dementia. A WWII veteran, David was recognized for his infinite dedication and service to his wife as a model caregiver.

Photo 2: Melissa Negrin-Wiener, Esq., senior partner, Cona Elder Law; Mr. David Marshall; Jennifer B. Cona, Esq. Managing Partner Cona Elder Law PLLC.

ABOUT CONA ELDER LAW: 

Cona Elder Law is an award-winning law firm concentrating in the areas of elder law, estate planning, estate administration and litigation, and health care law.  Cona Elder Law takes a holistic approach to elder law, providing support and resources for older adults and caregivers. The firm has been consistently ranked the #1 Elder Law Firm by various publications and industry awards.  For additional information, visit www.conaelderlaw.com.

Presented by Long Island Health Collaborative, Sponsored by AARP Long Island

The Long Island Health Collaborative has announced the return of  its annual AARP Long Island-sponsored Walk with a Doc series. Now in its third year, Long Islanders are invited to join the two organizations and their physician partners at the following free community walks on the third Saturday of May, June, September, and October.

The series aims to tackle chronic disease through free community walks where physicians will briefly speak about how attendees can prevent or better manage chronic conditions in their own lives through simple lifestyle choices like a balanced diet and regular physical activity before leading attendees on a walk where they can ask the doc questions and keep the conversation going.

All walks are FREE and walkers must register in advance to attend. State parking fees are waived. Learn more and register for each walk at the links below.

Walk with a Doc: Harborfront Park

Saturday, May 18, 2024 at 10 AM

Harborfront Park, Port Jefferson, NY 11777

Led by Dr. Shamim Khan, Interventional Cardiologist, Catholic Health

Register Here: https://www.eventbrite.com/e/852479829117

Walk with a Doc: Belmont Lake

Saturday, June 15, 2024 at 10 AM

Belmont Lake State Park

Led by Dr. Keasha S. Guerrier, Family Medicine, Long Island Jewish Valley Stream Hospital

Register Here: https://www.eventbrite.com/e/852497782817

Walk with a Doc: Sunken Meadow

Saturday, September 21, 2024 at 10 AM

Sunken Meadow State Park, New York State Reference Rte 908K, Kings Park, NY 11754

Led by Dr. Anupama Paranandi, Preventive Medicine Resident, Stony Brook Medicine

Special guest speakers from Suffolk County DOH’s Office of Minority Health and the Long Island Sound Study will discuss increasing equitable access to the Long Island Sound in the region and the Long Island Sound Estuary Program

Register Here: https://www.eventbrite.com/e/858998687197

 

Walk with a Doc: Hempstead Lake

Saturday, October 19, 2024 at 10 AM

Hempstead Lake State Park

Led by Dr. Gerard A. Baltazar, Critical Care Surgeon, NYU Langone Hospital

Register Here: https://www.eventbrite.com/e/858992087457

 

Why take a walk in the (New York State) park?

 According to the New York State Department of Health, chronic diseases such as asthma, cancer, diabetes, health disease, and stroke are the leading causes of disability and death in the United States. These conditions account for seven of every ten deaths and affect 90 million Americans. The good news is that these diseases are preventable with simple lifestyle choices, such as regular physical activity and a balanced diet. Walking is a simple, free way to get in regular physical activity that can help you manage or even prevent chronic conditions.

It’s no secret that Long Island is home to a multitude of scenic locations that lend themselves to safe, beautiful walking opportunities. In 2024,New York State Parks and Historic Sites also celebrates their Centennial, commemorating the 100th anniversary of the founding of our parks and sites system. Three of our four 2024 walks will be held at New York State Parks.

For more information about Walk with a Doc, contact Brooke Oliveri, Manager of the Long Island Health Collaborative at[email protected] or call 631-963-4167.

Stock photo

The Town of Smithtown will host a community blood drive at the Smithtown Senior Citizen Center, 420 Middle Country Road, Smithtown on Wednesday, May 15 from 9 a.m. to 3 p.m. Participating community members who donate blood will receive a free box of Girl Scout Cookies. Appointments are preferred by visiting www.nybc.org, however walk-ins will be welcomed. For further information, call Dineen at 631-360-7626.

Simple tests can confirm your kidney's health. METRO photo
Simple tests can confirm your kidney’s health.

By David Dunaief, M.D.

Dr. David Dunaief

Your kidneys perform an array of critical functions that help maintain your body’s systems. They filter waste and fluid from your body and maintain your blood’s health. They also help control your blood pressure, make red blood cells and vitamin D, and control your body’s acid levels.

If your kidney function degrades, it can lead to hypertension or cardiovascular problems and it may require dialysis or a kidney transplant in later stages. For the best outcomes, it’s critical to identify chronic kidney disease (CKD) early and strive to arrest its advance to more serious stages. However, of the estimated 35.5 million U.S. adults who have CKD, as many as 9 in 10 are not even aware they have it (1).

One of the challenges with identifying early-stage CKD is that symptoms are not obvious and can be overlooked. Among them are foamy urine, urinating more or less frequently than usual, itchy or dry skin, fatigue, nausea, appetite loss, and unintended weight loss (2).

Fortunately, there are simple tests, such as a basic metabolic panel and a urinalysis, that will confirm your kidney function. These indices for kidney function include an estimated glomerular filtration rate (eGFR), creatinine level and protein in the urine. eGFR is a calculation and, while the other two indices have varying ranges depending on the laboratory used, a patient with an eGFR of 30 to 59 is considered to have mild disease. The eGFR and the kidney function are inversely related, meaning as eGFR declines, the severity of CKD increases.

What can be done to address early-stage CKD, before complications occur? There are several studies that have evaluated different lifestyle modifications and their impacts on its prevention, treatment and reversal.

What causes the greatest risk to your kidneys?

Among the greatest risks for your kidneys are uncontrolled diseases and medical disorders, such as diabetes and hypertension (1). If you have — or are at risk for — diabetes, be sure to control your blood sugar levels to limit kidney damage. Similarly, if you currently have hypertension, controlling it will put less stress on your kidneys. For these diseases, it’s crucial that you have your kidney function tested at least once a year.

In addition, obesity and smoking have been identified as risk factors and can be managed by making lifestyle changes to reduce your risk.

Can changing your diet help protect your kidneys?

Fruits and vegetables may play a role in helping patients with CKD. In a one-year study with 77 patients, results showed that fruits and vegetables work as well as sodium bicarbonate in improving kidney function by reducing metabolic acidosis levels (3).

What is the significance of metabolic acidosis? It means that body fluids become acidic, and it is associated with CKD. The authors concluded that both sodium bicarbonate and a diet including fruits and vegetables were renoprotective, helping to protect the kidneys from further damage in patients with CKD. Alkali diets are primarily plant-based, although not necessarily vegetarian or vegan. Animal products tend to cause an acidic environment.

In the Nurses’ Health Study, results show that animal fat, red meat and sodium all negatively impact kidney function (4). The risk of protein in the urine, a potential indicator of CKD, increased by 72 percent in those participants who consumed the highest amounts of animal fat compared to the lowest, and by 51 percent in those who ate red meat at least twice a week. With higher amounts of sodium, there was a 52 percent increased risk of having lower eGFR levels.

The most interesting part with sodium was that the difference between higher mean consumption and the lower mean consumption was not that large, 2.4 grams compared to 1.7 grams. In other words, a difference of approximately a quarter-teaspoon of sodium per day was responsible for the decrease in kidney function.

The National Kidney Foundation recommends diets that are higher in fruit and vegetable content and lower in animal protein, including the Dietary Approaches to Stop Hypertension (DASH) diet and plant-based diets (2). 

In my practice, when CKD patients follow a vegetable-rich, nutrient-dense diet, there are substantial improvements in kidney functioning. For instance, for one patient, his baseline eGFR was 54. After one month of dietary changes, his eGFR improved by 9 points to 63, which is a return to “normal” functioning of the kidney. Note that this is anecdotal, not a study.

When should you have your kidney function tested?

It is important to have your kidney function checked. If your levels are low, you should address the issue through medications and lifestyle modifications to manage and reverse early-stage CKD. If you have common risk factors, such as diabetes, smoking, obesity or high blood pressure, or if you are over 60 years old, talk to your doctor about regular testing. 

Don’t wait until symptoms and complications occur. In my experience, it is much easier to treat and reverse CKD in its earlier stages.

References:

(1) CDC.gov. (2) kidney.org. (3) Clin J Am Soc Nephrol. 2013;8:371-381. (4) Clin J Am Soc Nephrol. 2010; 5:836-843.

Dr. David Dunaief is a speaker, author and local lifestyle medicine physician focusing on the integration of medicine, nutrition, fitness and stress management. For further information, visit www.medicalcompassmd.com or consult your personal physician.